Long-term intraocular pressure–lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with timoptic XE 0.5% in a 12-month study11All proprietary rights for this study are retained by Alcon Research, Ltd.-Reference-Cited by-同舟云学术

Long-term intraocular pressure–lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with timoptic XE 0.5% in a 12-month study11All proprietary rights for this study are retained by Alcon Research, Ltd.

Published:2000-08 Issue:2 Volume:130 Page:145-150
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Schenker Howard I,Silver Lewis H

Publisher

Elsevier BV

Subject

Ophthalmology

Reference7 articles.

1. Timolol, dose response and duration of action;Zimmerman;Arch Ophthalmol,1977

2. The intraocular pressure lowering effect of timolol in gel forming solution;Rosenlund;Acta Ophthalmol Scand,1996

3. Multicentrische Doppleblind studie mit 0,25% Timolol in Gelrite (TG) 1 mal vs. 0,25% Timolol-losung (TS) 2 mal taglich;Hommer;Ophthalmologe,1995

4. Comparison of the effects of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged men;Dickstein;Am J Ophthalmol,1996

5. Applications of xanthan gum;Sanderson;Br Polymer J,1981

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plant polysaccharides in ocular drug delivery;Plant Polysaccharides as Pharmaceutical Excipients;2023

2. Bioadhesive Systems Targeting Site-Specific Mucosal Delivery;Current Nanomedicine;2022-11

3. Ocular Bioadhesive Drug Delivery Systems and Their Applications;Bioadhesives in Drug Delivery;2020-05-22

4. Point-of-Care Nanoplatforms for Glaucoma and Age-Related Macular Degeneration: Clinical Implications and Emerging Concepts;Nanoformulations in Human Health;2020

North American cost analysis of brand name versus generic drugs for the treatment of glaucoma

;ClinicoEconomics and Outcomes Research;2019-12